Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Microbial Therapeutics for Metabolic Dysfunction-Associated Steatotic Liver Disease: From Mechanistic Investigations to Clinical Trials

NCT07488975 is registered in ClinicalTrials.gov with Leeuwenhoek Laboratories Co. Ltd. as lead sponsor.

NCT NCT07488975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07488975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Microbial Therapeutics for Metabolic Dysfunction-Associated Steatotic Liver Disease: From Mechanistic Investigations to Clinical Trials
Lead sponsor
Leeuwenhoek Laboratories Co. Ltd.
Phase
Phase 1
Overall status
Active, not recruiting
Start date
January 22, 2025
Completion date
December 31, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic dysfunction-associated steatotic liver disease